Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 10/2009

01-10-2009 | Letter to the Editor

Hepatitis C antiviral response in thalassemia: what is the role of liver iron concentration?

Authors: Ali T. Taher, Khaled M. Musallam, Mohamad Khalife, Kassem Barada

Published in: Annals of Hematology | Issue 10/2009

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
3.
4.
Lin TJ, Liao LY, Lin CL et al (2008) Hepatic iron influences responses to combination therapy with peginterferon alfa and ribavirin in chronic hepatitis C. Hepatogastroenterology 55:1412–1415PubMed
5.
6.
Iwasa M, Kaito M, Ikoma J et al (2002) Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients. Hepatogastroenterology 49:529–531PubMed
7.
Goubran HA, Essmat G, Morcos HH, et al (2007) Pilot results: pre-treatment with deferasirox increases the chances of rapid viral response in patients with chronic hepatitis c infection treated with peg-interferon/ribavirin. Blood 110. Abstract 2281.
8.
Mahmoud A, Musallam KM, Taher AT (2008) Iron and hepatitis C: what can we learn from thalassaemia major? Liver Int 28:892–893PubMedCrossRef
9.
Metadata
Title
Hepatitis C antiviral response in thalassemia: what is the role of liver iron concentration?
Authors
Ali T. Taher
Khaled M. Musallam
Mohamad Khalife
Kassem Barada
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 10/2009
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0713-y

Other articles of this Issue 10/2009

Annals of Hematology 10/2009 Go to the issue

Letter to the Editor

Telomere length of donors influences granulocyte recovery in children after hematopoietic stem cell transplantation

Letter to the Editor

Cutaneous myeloma and bortezomib

Letter to the Editor

ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?

Original Article

Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up

Original Article

Stroke prevention in the young child with sickle cell anaemia

Letter to the Editor

Intrathecal chemotherapy—a word of caution
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits